SCHEMBL13046754

SCHEMBL13046754

O=C(Nc1cccc2c(=O)n(CC3CCOCC3)ccc12)c1ccc2ccccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
GAA P10253 1/20 0.42
CASP1 P29466 2/20 0.42
NR1H4 Q96RI1 1/20 0.41
CNR2 P34972 4/20 0.41
CNR1 P21554 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
P2RX7 Q99572 2/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13047696 0.88 NPC1 (0.44) GPR35GPR55NPC1RAB9AKDM4E
SCHEMBL13047416 0.87 CCR8 (0.42) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL13046744 0.86 PIK3CD (0.46) GPR35KMT2AKDM4EMEN1LMNA
SCHEMBL13046753 0.86 CNR1 (0.55) NPC1RAB9AKDM4EMAPTCASP1
SCHEMBL13046803 0.85 RAB9A (0.46) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL13046619 0.85 HSD17B13 (0.42) RAB9ALMNACNR1P2RX7ALDH1A1
SCHEMBL13046817 0.85 HTR2B (0.39) KMT2AKDM4EMEN1LMNAMAPT
SCHEMBL13046798 0.85 RAB9A (0.46) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL13046740 0.84 TSHR (0.49) KMT2AKDM4EMEN1LMNAMAPT
SCHEMBL13047425 0.84 CYP1A2 (0.56) GPR35GPR55NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 GPR35 73/4885GPR55 94/4885NPC1 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.